Loading...

ATYR ATYR PHARMA INC Management Changes 8-K Filing

TYR

TYR

ATYR PHARMA INC

(ATYR)

2024 8-K

Show Summary

Show Summary

Financial Statements

Stock Option Plans

Financial Results

Share Offering Update

Director Appointment

Financial Results

Financial Results

Clinical Trial Enrollment C...

Annual Meeting Approval

Earnings Reports

Earnings Reports

Financial Results Announcement

Investor Conferences

Presentation of Study Results

Financial Results Announcement

Annual Meeting Approval

Financial Results Announcement

Disinvestment of Assets

Financial Results Announcement

Public Offering

Phase 3 Study Milestone

External Links:

Atyr Pharma appointed Eric Benevich as a Class II director effective December 10, 2024, and amended its Non-Employee Director Compensation Policy, granting him options to purchase 100,000 shares of common stock.

AI Assistant

ATYR PHARMA INC

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.